Mangoceuticals (MGRX) Net Shares Issued and Repurchased (2022 - 2025)

Mangoceuticals has disclosed Net Shares Issued and Repurchased across 4 years of filings, most recently posting $2.0 million for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased rose 5900.06% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (up 5900.06% YoY), while the FY2025 annual figure was $2.0 million, up 5900.06% from the prior year.
• Net Shares Issued and Repurchased came in at $2.0 million for Q4 2025 at Mangoceuticals, up from $33333.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.0 million in Q4 2025 to a low of $33333.0 in Q4 2024.
• Average Net Shares Issued and Repurchased over 4 years is $731999.8, with a median of $283333.0 recorded in 2024.
• Year-over-year, Net Shares Issued and Repurchased plunged 92.53% in 2023 and surged 5900.06% in 2025.
• Over 4 years, Net Shares Issued and Repurchased stood at $1.2 million in 2022, then plunged by 92.53% to $93333.0 in 2023, then tumbled by 64.29% to $33333.0 in 2024, then surged by 5900.06% to $2.0 million in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $2.0 million in Q4 2025, $33333.0 in Q4 2024, and $283333.0 in Q1 2024.